Unleashing the therapeutic potential of NOD-like receptors.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Works matching IS 14741776 AND DT 2009 AND VI 8 AND IP 6
Results: 26
1
2
Development of pharmacotherapies for drug addiction: a Rosetta stone approach.
- Published in:
- 2009
- By:
- Publication type:
- journal article
3
Targeting innate immunity protein kinase signalling in inflammation.
- Published in:
- 2009
- By:
- Publication type:
- journal article
4
Prasugrel.
- Published in:
- 2009
- By:
- Publication type:
- research
5
Neurodegenerative disease: Draining SAP to target Alzheimer's disease.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 6, p. 454, doi. 10.1038/nrd2900
- By:
- Publication type:
- Article
6
Anticancer drugs: Selectively targeting turnover.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 6, p. 453, doi. 10.1038/nrd2901
- By:
- Publication type:
- Article
7
Antimalarial drugs: Double whammy.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 6, p. 451, doi. 10.1038/nrd2902
- By:
- Publication type:
- Article
8
Anticancer drugs: New approaches to anti-androgen activities.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 6, p. 452, doi. 10.1038/nrd2903
- By:
- Publication type:
- Article
9
Obesity: Calorie-burning fat found in adults.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 6, p. 452, doi. 10.1038/nrd2904
- By:
- Publication type:
- Article
10
In Brief.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 6, p. 454, doi. 10.1038/nrd2905
- Publication type:
- Article
11
Pedro Cuatrecasas.
- Published in:
- 2009
- By:
- Publication type:
- Interview
12
Chronic myelogenous leukaemia market.
- Published in:
- 2009
- By:
- Publication type:
- journal article
13
Trial watch: Phase 0 trials for anticancer drug development.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 6, p. 442, doi. 10.1038/nrd2910
- Publication type:
- Article
14
Deal watch: Monoclonal antibodies targeting Clostridium difficile licensed to Merck.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 6, p. 442, doi. 10.1038/nrd2911
- Publication type:
- Article
15
Market watch: Sales from licensed and acquired products to increase by 2013.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 6, p. 443, doi. 10.1038/nrd2912
- By:
- Publication type:
- Article
16
Toxicology.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 6, p. 517, doi. 10.1038/nrd2913
- Publication type:
- Article
17
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 6, p. 433, doi. 10.1038/nrd2915
- Publication type:
- Article
18
Novel anticancer strategy targets DNA repair.
- Published in:
- 2009
- By:
- Publication type:
- journal article
19
Tapping into combination pills for HIV.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 6, p. 439, doi. 10.1038/nrd2917
- By:
- Publication type:
- Article
20
Vertical disintegration: a strategy for pharmaceutical businesses in 2009?
- Published in:
- 2009
- By:
- Publication type:
- Editorial
21
Knocking down barriers: advances in siRNA delivery.
- Published in:
- 2009
- By:
- Publication type:
- Correction Notice
22
Sirtuins — novel therapeutic targets to treat age-associated diseases.
- Published in:
- 2009
- By:
- Publication type:
- Correction Notice
23
Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes.
- Published in:
- 2009
- By:
- Publication type:
- Correction Notice
24
Mechanisms of drug combinations: interaction and network perspectives.
- Published in:
- 2009
- By:
- Publication type:
- Correction Notice
25
Chronic myelogenous leukaemia market.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 6, p. 447, doi. 10.1038/nrd2873
- By:
- Publication type:
- Article
26
Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008.
- Published in:
- 2009
- By:
- Publication type:
- review